<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03266913</url>
  </required_header>
  <id_info>
    <org_study_id>4889</org_study_id>
    <nct_id>NCT03266913</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia</brief_title>
  <official_title>Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hormozgan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hormozgan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neonatal Jaundice occurs in 60% of term infants and 80% of premature infants. Although it is
      transient, it is associated with high rate of readmission of patients in the first week of
      infancy. Neonatal jaundice can cause neurological complications and kernicterus. Considering
      the fact that there have been a lot of studies on probiotic role in management of necrotizing
      enterocolitis (NEC) and few studies on their role in neonatal jaundice, we carried out this
      study to determine the efficacy and safety of probiotics in neonatal hyperbilirubinemia in
      infants hospitalized in children hospital in Bandar Abbas.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of phototherapy</measure>
    <time_frame>6 days</time_frame>
    <description>Duration of phototherapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discharge rate</measure>
    <time_frame>6 days</time_frame>
    <description>percentage of infants discharged from the hospital at 2nd, 3rd, 4th, and 5th days of admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Hyperbilirubinemia, Neonatal</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Routine phototherapy plus probiotic oral drops at the dose of 10 drops daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No probiotic</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Routine phototherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>Probiotics drop</description>
    <arm_group_label>Probiotic</arm_group_label>
    <other_name>PediLact</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 2 and 28 days old

          -  Having jaundice

          -  Gestational age between 35-42 weeks

        Exclusion Criteria:

          -  Less than 2 days or more than 28 days old

          -  Gestational age out of the range of 35-42 weeks

          -  Infants whose parents refused to cooperate

          -  Patients with sepsis and other comorbid conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rakhshaneh Goodarzi, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hormozgan University of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rakhshaneh Goodarzi, M.D</last_name>
    <phone>+989123004060</phone>
    <email>rakhshanehgoodarzi@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children hospital</name>
      <address>
        <city>Bandar Abbas</city>
        <state>Hormozgan</state>
        <zip>763</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rakhshaneh Goodarzi</last_name>
      <phone>+989123004060</phone>
      <email>rakhshanehgoodarzi@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2017</study_first_submitted>
  <study_first_submitted_qc>August 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2017</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hormozgan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Hamidreza Mahboobi</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperbilirubinemia</mesh_term>
    <mesh_term>Hyperbilirubinemia, Neonatal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

